We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $8.34B
1-Year Est. Return 165.53%
This Fund
S&P 500
This Quarter Est. Return
+77.9%
1 Year Est. Return
+165.53%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.34B
AUM Growth
+$2.35B
Cap. Flow
-$42M
Cap. Flow %
-0.5%
Top 10 Hldgs %
46.57%
Holding
644
New
20
Increased
132
Reduced
424
Closed
57

Top Buys

Rank Stock Value
1
INIO
INNIO N.V.
INIO
+$177M
2
AMD icon
Advanced Micro Devices
AMD
+$119M
3
FORM icon
FormFactor
FORM
+$101M
4
CBRS
Cerebras Systems
CBRS
+$70.1M
5
ONTO icon
Onto Innovation
ONTO
+$64.5M

Top Sells

Rank Stock Value
1
TSEM icon
Tower Semiconductor
TSEM
+$220M
2
LITE icon
Lumentum
LITE
+$219M
3
TSLA icon
Tesla
TSLA
+$50.1M
4
CIEN icon
Ciena
CIEN
+$43.3M
5
MSFT icon
Microsoft
MSFT
+$42.6M

Sector Composition

Rank Sector Weight
1 Technology 66.11%
2 Communication Services 9.64%
3 Consumer Discretionary 8.42%
4 Industrials 4.35%
5 Healthcare 4.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NAMS icon
351
NewAmsterdam Pharma
NAMS
$3.04B
$82.5K ﹤0.01%
2,434
-112
-4% -$3.69K
MAC icon
352
Macerich
MAC
$6.59B
$82.1K ﹤0.01%
3,259
-561
-15% -$12.6K
CLNE icon
353
Clean Energy Fuels
CLNE
$364M
$81.2K ﹤0.01%
39,587
-16,758
-30% -$35.6K
RLAY icon
354
Relay Therapeutics
RLAY
$4.17B
$79.3K ﹤0.01%
4,239
+363
+9% +$5.27K
DYN icon
355
Dyne Therapeutics
DYN
$4.53B
$77.4K ﹤0.01%
3,485
+277
+9% +$5.15K
KRG icon
356
Kite Realty
KRG
$5.2B
$77.2K ﹤0.01%
2,721
-602
-18% -$16.2K
ALMS
357
Alumis Inc
ALMS
$1.44B
$75.3K ﹤0.01%
2,677
+494
+23% +$11.5K
BEAM icon
358
Beam Therapeutics
BEAM
$3.06B
$74.1K ﹤0.01%
2,159
-120
-5% -$3.62K
PECO icon
359
Phillips Edison & Co
PECO
$5.01B
$70.9K ﹤0.01%
1,704
-196
-10% -$7.83K
ADPT icon
360
Adaptive Biotechnologies
ADPT
$3.87B
$69.9K ﹤0.01%
3,260
-170
-5% -$2.6K
IDYA icon
361
IDEAYA Biosciences
IDYA
$3.85B
$69.3K ﹤0.01%
1,860
-109
-6% -$3.34K
MRSH
362
Marsh
MRSH
$88.6B
$69.2K ﹤0.01%
415
– –
ARQT icon
363
Arcutis Biotherapeutics
ARQT
$3B
$68.9K ﹤0.01%
2,626
-125
-5% -$2.91K
RARE icon
364
Ultragenyx Pharmaceutical
RARE
$1.51B
$68.3K ﹤0.01%
2,045
-121
-6% -$3.01K
CUZ icon
365
Cousins Properties
CUZ
$4.79B
$66.6K ﹤0.01%
2,223
-316
-12% -$8.29K
SBRA icon
366
Sabra Healthcare REIT
SBRA
$5.31B
$65.8K ﹤0.01%
3,372
-252
-7% -$5K
VERA icon
367
Vera Therapeutics
VERA
$2.59B
$64.9K ﹤0.01%
1,512
+76
+5% +$2.83K
ELVN icon
368
Enliven Therapeutics
ELVN
$4.35B
$63.8K ﹤0.01%
1,258
-75
-6% -$3.18K
KNSA icon
369
Kiniksa Pharmaceuticals
KNSA
$6.08B
$62.2K ﹤0.01%
973
-42
-4% -$2.18K
MRP
370
Millrose Properties Inc
MRP
$5.32B
$61.4K ﹤0.01%
2,042
+177
+9% +$5.12K
QURE icon
371
uniQure
QURE
$3.09B
$60.8K ﹤0.01%
1,320
-69
-5% -$1.81K
COLD icon
372
Americold
COLD
$4.06B
$60.4K ﹤0.01%
3,840
-465
-11% -$6.38K
SKT icon
373
Tanger
SKT
$4.29B
$60.3K ﹤0.01%
1,528
-183
-11% -$6.78K
EPR icon
374
EPR Properties
EPR
$4.6B
$59.9K ﹤0.01%
1,032
-119
-10% -$6.77K
IRON icon
375
Disc Medicine
IRON
$3.04B
$59.2K ﹤0.01%
809
-39
-5% -$2.68K
13 14
15
16 17

Similar funds

GLF
Groupe la Francaise Paris, France $8.31B AUM 37.53% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
MWM
Modern Wealth Management Lenexa, Kansas $8.4B AUM 21.02% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
OCA
OpenArc Corporate Advisory Atlanta, Georgia $8.41B AUM

GF Fund Management's Q2 2026 Portfolio in Review

As of Q2 2026, GF Fund Management held 644 positions worth $8.34B, up 39% from $5.98B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

GF Fund Management's Q2 2026 filing shows 20 new, 132 increased, 424 reduced and 57 closed positions. Its largest new stake was INNIO N.V.: 4,970,000 shares worth $197M. The largest sale was Tower Semiconductor, an estimated $220M.

By sector, the portfolio is most concentrated in Technology at 66% of assets, up from 54% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q2 2026 buy was INNIO N.V.: 4,970,000 shares worth $197M.
  • GF Fund Management added most to Advanced Micro Devices in Q2 2026, an estimated $119M increase.
  • GF Fund Management's biggest Q2 2026 reduction was Tower Semiconductor, cutting an estimated $220M.
  • GF Fund Management fully exited Coherent in Q2 2026, selling an estimated $23.3M.
  • GF Fund Management's ten largest holdings make up 47% of its $8.34B portfolio in Q2 2026.
  • GF Fund Management opened 20 new positions and closed 57 in Q2 2026.
  • GF Fund Management's portfolio value rose 39% quarter-over-quarter to $8.34B.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.